A national strategy is needed to tackle health risks linked to antipsychotic drugs because current policy is letting tens of thousands of people fall through the gaps, commissioners in London are warning.
A panel of experts explored how understanding what patients want out of medicines and redefining the concept of ‘value’ are at the heart of the growing challenge of medicines adherence
Julie Wood explores the need to do more at local level and how commissioners are working with provider partners to change their relationships and find bespoke solutions to local problems
